Showing results (301-310 of 361) with videos related to
Sort By:
Pageof 37
MDM Policy & Practice|July 2, 2021
Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian ProvincesReka E Pataky, Jaclyn Beca, David Tran, et al.BMC Cancer|April 16, 2020
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, CanadaWei Fang Dai, Jaclyn M Beca, Ruth Croxford, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancerJeffrey A Meyerhardt, Andrew X Zhu, Peter C Enzinger, et al.Journal of Geriatric Oncology|July 3, 2020
The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, CanadaPhillip S Blanchette, Melody Lam, Britney Le, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 8, 2007
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancerJ A Meyerhardt, K Stuart, C S Fuchs, et al.Journal of Surgical Oncology|August 22, 2009
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancerC C Earle, M R Weiser, A Ter Veer, et al.JAMA Network Open|November 15, 2021
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic CancerMichael J Raphael, William Raskin, Steven Habbous, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2021
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian ProvincesJ M Beca, W F Dai, R E Pataky, et al.Breast Cancer Research and Treatment|October 2, 2019
Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, CanadaPhillip S Blanchette, Melody Lam, Lucie Richard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2012
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumorsJennifer A Chan, Keith Stuart, Craig C Earle, et al.Pageof 37